Literature DB >> 21416248

Use of small doses of furosemide in chronic kidney disease patients with residual renal function undergoing hemodialysis.

Helton P Lemes1, Salustiano Araujo, Daniella Nascimento, Danny Cunha, Cesar Garcia, Vinicius Queiroz, Sebastião R Ferreira-Filho.   

Abstract

BACKGROUND: The objective of the present study was to verify whether chronic renal patients on hemodialysis (HD) with residual diuresis who were using small doses of furosemide present different levels of urinary volume and sodium excretion compared to patients with residual diuresis who do not use this drug.
METHODS: We studied 19 chronic renal patients on HD who presented any level of residual diuresis. Urine was collected during the 24-h interdialytic period, and physical examinations and blood sampling took place immediately before the start of HD. Patients were divided into two groups: the diuretic group (DG, n = 10), in which patients had been using 40 mg of furosemide for at least 3 months, and the non-diuretic group (NDG, n = 9), in which patients used no diuretics.
RESULTS: Although both groups presented the same average glomerular filtration rate (p > 0.05) and time in dialysis (p > 0.05) the DG presented an average of twice the urinary volume in 24 h (1142 ± 184 vs. 453 ± 135 ml/24 h, respectively; p = 0.008) and double the total excreted sodium mass compared to patients in the NDG (112 ± 22.4 vs. 45.2 ± 16.0 mEq/24 h, respectively; p = 0.02).
CONCLUSION: The results of this study have shown that chronic use of small doses of furosemide in chronic renal patients with residual diuresis could increase urinary volume and sodium excretion compared to patients who did not use this drug.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21416248     DOI: 10.1007/s10157-011-0427-z

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  26 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Mechanism of impaired natriuretic response to furosemide during prolonged therapy.

Authors:  N R Loon; C S Wilcox; R J Unwin
Journal:  Kidney Int       Date:  1989-10       Impact factor: 10.612

Review 3.  Augmenting solute clearance in peritoneal dialysis.

Authors:  R T Krediet; C E Douma; R W van Olden; M M Ho-dac-Pannekeet; D G Struijk
Journal:  Kidney Int       Date:  1998-12       Impact factor: 10.612

4.  Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis.

Authors:  J F Medcalf; K P Harris; J Walls
Journal:  Kidney Int       Date:  2001-03       Impact factor: 10.612

5.  Use of single voided urine samples to estimate quantitative proteinuria.

Authors:  J M Ginsberg; B S Chang; R A Matarese; S Garella
Journal:  N Engl J Med       Date:  1983-12-22       Impact factor: 91.245

6.  Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers.

Authors:  L C Smeby; T E Widerøe; T Balstad; S Jørstad
Journal:  Blood Purif       Date:  1986       Impact factor: 2.614

7.  The influence of dialysis treatment modality on the decline of remaining renal function.

Authors:  M J Lysaght; E F Vonesh; F Gotch; L Ibels; M Keen; B Lindholm; K D Nolph; C A Pollock; B Prowant; P C Farrell
Journal:  ASAIO Trans       Date:  1991 Oct-Dec

8.  Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency.

Authors:  R W van Olden; J J van Meyel; P G Gerlag
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

9.  The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.

Authors:  Srinivas Sanjay; Rajeev A Annigeri; Rajagopalan Seshadri; Budithi Subba Rao; Kowdle C Prakash; Muthu Krishna Mani
Journal:  Nephrology (Carlton)       Date:  2008-06       Impact factor: 2.506

10.  Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis.

Authors:  R W van Olden; R T Krediet; D G Struijk; L Arisz
Journal:  J Am Soc Nephrol       Date:  1996-05       Impact factor: 10.121

View more
  10 in total

Review 1.  Hypertension in Pediatric Dialysis Patients: Etiology, Evaluation, and Management.

Authors:  Raj Munshi; Joseph T Flynn
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

2.  Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients.

Authors:  Yoshitsugu Obi; Connie M Rhee; Anna T Mathew; Gaurang Shah; Elani Streja; Steven M Brunelli; Csaba P Kovesdy; Rajnish Mehrotra; Kamyar Kalantar-Zadeh
Journal:  J Am Soc Nephrol       Date:  2016-05-11       Impact factor: 10.121

Review 3.  Pharmacotherapy of Hypertension in Chronic Dialysis Patients.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

Review 4.  Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

Review 5.  Strategies for the preservation of residual renal function in pediatric dialysis patients.

Authors:  Melissa A Cadnapaphornchai; Isaac Teitelbaum
Journal:  Pediatr Nephrol       Date:  2013-07-19       Impact factor: 3.714

Review 6.  Blood pressure control in conventional hemodialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Semin Dial       Date:  2018-08-06       Impact factor: 3.455

7.  Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Authors:  Jennifer E Flythe; Tara I Chang; Martin P Gallagher; Elizabeth Lindley; Magdalena Madero; Pantelis A Sarafidis; Mark L Unruh; Angela Yee-Moon Wang; Daniel E Weiner; Michael Cheung; Michel Jadoul; Wolfgang C Winkelmayer; Kevan R Polkinghorne
Journal:  Kidney Int       Date:  2020-03-08       Impact factor: 10.612

8.  Impact of timing of initiation of dialysis on long-term prognosis of patients undergoing hemodialysis.

Authors:  Yumei Zhang; Chun Hu; Zhixiang Bian; Peihua Chen
Journal:  Exp Ther Med       Date:  2018-06-08       Impact factor: 2.447

9.  Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.

Authors:  Akio Nakashima; Ichiro Ohkido; Keitaro Yokoyama; Aki Mafune; Mitsuyoshi Urashima; Takashi Yokoo
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

10.  Efficacy and safety of furosemide for prevention of intradialytic hypotension in haemodialysis patients: protocol for a multicentre randomised controlled trial.

Authors:  Wenwen Chen; Fang Wang; Yuliang Zhao; Ling Zhang; Zhiwen Chen; Mingjin Dai
Journal:  BMJ Open       Date:  2021-07-05       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.